What does SAELENS PHARMA do?

SAELENS PHARMA is registered with the CBE as active in: Activiteiten van holdings. Private Limited, started on 10 March 2014, 1 establishment.

What is the address of SAELENS PHARMA?

The registered office of SAELENS PHARMA is located at Paardenmarkt 7, 8970 Poperinge.

Is SAELENS PHARMA still active?

Yes. According to the CBE (30 October 2026) SAELENS PHARMA is active, legal situation “Normale toestand”, started on 10 March 2014.

Is SAELENS PHARMA registered on Peppol?

Yes, SAELENS PHARMA is registered on the Peppol network with ID 0208:0547787407.

What is the enterprise number of SAELENS PHARMA?

The enterprise number of SAELENS PHARMA is BE0547787407.

When was SAELENS PHARMA founded?

SAELENS PHARMA was founded on 10 March 2014.

Who are the directors of SAELENS PHARMA?

According to the 2025 annual accounts, the directors of SAELENS PHARMA are: Sigrid Saelens.

Is SAELENS PHARMA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 10 March 2014; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did SAELENS PHARMA make in 2025?

SAELENS PHARMA posted a profit after taxes of € 109,642 in financial year 2025.

What is the revenue of SAELENS PHARMA?

As a small company, SAELENS PHARMA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 178,191.

Does SAELENS PHARMA have a website?

Yes, SAELENS PHARMA has a website at apotheeksaelens.be.

SAELENS PHARMA (Private Limited) - Poperinge

Dossier SAELENS PHARMA, printed on 30 October 2026 from databakkes.be/en/0547787407/saelens-pharma. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

SAELENS PHARMA from Poperinge, company number BE0547787407, closed financial year 2025 with a result of € 109,642 after tax. For that financial year SAELENS PHARMA recorded a gross margin of € 178,191 and equity of € 1.2 million. Compared with financial year 2024, the result moved from € 99,918 to € 109,642. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 29, 2026.

What it is worth Healthy

€ 1.2 million

▼ 6% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 109,642

▲ 10% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 195,617

▲ 25% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 185,642 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 1,191

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 4,273

▲ 264% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 5,370

▼ 77% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 266,600 Revenue 2022: € 266,600 First fiscal year in the series	-	-	-
Gross margin	€ 213,152 Gross margin 2022: € 213,152 First fiscal year in the series	€ 176,532 Gross margin 2023: € 176,532 ▼ 17% vs 2022 (€ 213,152) Unfavourable step	€ 178,892 Gross margin 2024: € 178,892 ▲ 1% vs 2023 (€ 176,532) Favourable step	€ 178,191 Gross margin 2025: € 178,191 Unchanged (€ 178,892) Unfavourable step
Profit after taxes	€ 127,440 Profit after taxes 2022: € 127,440 First fiscal year in the series	€ 81,037 Profit after taxes 2023: € 81,037 ▼ 36% vs 2022 (€ 127,440) Unfavourable step	€ 99,918 Profit after taxes 2024: € 99,918 ▲ 23% vs 2023 (€ 81,037) Favourable step	€ 109,642 Profit after taxes 2025: € 109,642 ▲ 10% vs 2024 (€ 99,918) Favourable step	▲ 10%
Equity	€ 1,062,380 Equity 2022: € 1,062,380 First fiscal year in the series	€ 1,143,417 Equity 2023: € 1,143,417 ▲ 8% vs 2022 (€ 1,062,380) Favourable step	€ 1,243,335 Equity 2024: € 1,243,335 ▲ 9% vs 2023 (€ 1,143,417) Favourable step	€ 1,167,335 Equity 2025: € 1,167,335 ▼ 6% vs 2024 (€ 1,243,335) Unfavourable step	▼ 6%
Total debts	€ 527,692 Total debts 2022: € 527,692 First fiscal year in the series	€ 423,988 Total debts 2023: € 423,988 ▼ 20% vs 2022 (€ 527,692) Favourable step	€ 398,361 Total debts 2024: € 398,361 ▼ 6% vs 2023 (€ 423,988) Favourable step	€ 490,034 Total debts 2025: € 490,034 ▲ 23% vs 2024 (€ 398,361) Unfavourable step	▲ 23%
Cash	€ 64,074 Cash 2022: € 64,074 First fiscal year in the series	€ 63,086 Cash 2023: € 63,086 ▼ 2% vs 2022 (€ 64,074) Unfavourable step	€ 156,335 Cash 2024: € 156,335 ▲ 148% vs 2023 (€ 63,086) Favourable step	€ 195,617 Cash 2025: € 195,617 ▲ 25% vs 2024 (€ 156,335) Favourable step	▲ 25%
Land & buildings	€ 312,673 Land & buildings 2022: € 312,673 First fiscal year in the series	€ 301,457 Land & buildings 2023: € 301,457 ▼ 4% vs 2022 (€ 312,673) Unchanged	€ 290,242 Land & buildings 2024: € 290,242 ▼ 4% vs 2023 (€ 301,457) Unchanged	€ 279,026 Land & buildings 2025: € 279,026 ▼ 4% vs 2024 (€ 290,242) Unchanged	▼ 4%
Retained profit	€ 812,380 Retained profit 2022: € 812,380 First fiscal year in the series	€ 893,417 Retained profit 2023: € 893,417 ▲ 10% vs 2022 (€ 812,380) Favourable step	€ 993,335 Retained profit 2024: € 993,335 ▲ 11% vs 2023 (€ 893,417) Favourable step	€ 917,335 Retained profit 2025: € 917,335 ▼ 8% vs 2024 (€ 993,335) Unfavourable step	▼ 8%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 185,642 Dividend 2025: € 185,642 Unchanged (€ 0) Unchanged
Bank debt	€ 121,755 Bank debt 2022: € 121,755 First fiscal year in the series	€ 24,682 Bank debt 2023: € 24,682 ▼ 80% vs 2022 (€ 121,755) Favourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 24,682) Favourable step	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 1,590,072 Balance sheet total 2022: € 1,590,072 First fiscal year in the series	€ 1,567,406 Balance sheet total 2023: € 1,567,406 ▼ 1% vs 2022 (€ 1,590,072) Unchanged	€ 1,641,696 Balance sheet total 2024: € 1,641,696 ▲ 5% vs 2023 (€ 1,567,406) Unchanged	€ 1,657,369 Balance sheet total 2025: € 1,657,369 ▲ 1% vs 2024 (€ 1,641,696) Unchanged	▲ 1%

Key figures of SAELENS PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to SAELENS PHARMA?

What happened at SAELENS PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 29, 2026 New annual accounts for financial year 2025: profit of € 109,642 (▲ 10% vs 2024). Source: NBB ↗
Apr 1, 2014 New establishment in Poperinge. KBO
Mar 10, 2014 Start of the company according to the CBE. KBO

In short

From € 127,440 profit in 2022 to € 109,642 profit in 2025.

Paid € 161,334 in corporate taxes since 2022.

Best year ever: 2022, with € 127,440 profit.

Paid out € 185,642 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Sigrid Saelens

SAELENS PHARMA

Apotheek Sigrid Saelens 99%

Behind SAELENS PHARMA is Sigrid Saelens. It owns 99% of Apotheek Sigrid Saelens itself.

Directors

According to the 2025 annual accounts

Sigrid Saelens

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Paardenmarkt 7

8970 Poperinge

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Apotheek Sigrid Saelens same network

€ 138,640 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS apotheeksaelens.be

Technologies

ApacheGoogle MapsPHPVarnish

Certifications & Partners

RIZIV

Hosting & Email

Email provider

one.com Mail

Hosting

ONECOM, DK

Website info

HTTPS Ja

Languages EN

Features

Contact page

Security

✓ HTTPS

✗ SPF

✗ DMARC

Network

✓ IPv6

Details

Company number

0547.787.407

VAT number

BE 0547.787.407

Registered office

Paardenmarkt 7, 8970 Poperinge

Names & denominations

SAELENS PHARMA

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

10 March 2014

Peppol

Active · Active since 16 Nov 2025

Contact

apotheeksaelens.be

Activities · NACE

Activiteiten van holdings

Holdings

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Verhuur en exploitatie van eigen of geleased niet-residentieel onroerend goed, exclusief terreinen

Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen

Overige zakelijke dienstverlening, neg

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

View on CBE Public ↗ Annual accounts (NBB) ↗

SAELENS PHARMA

Financials

What happened to SAELENS PHARMA?

Management

Directors

Establishments

Establishment units

Who else lives here?

Website

Technologies

Certifications & Partners

Hosting & Email

Website info

Features

Security

Network

Details

Frequently asked questions